Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

GSK will provide Innovax with the adjuvant need for a preclinical test of the vaccine which is based on a series of truncated S (spike) proteins from the novel coronavirus SARS-CoV-2 that causes ...

GSK's vaccine against respiratory syncytial virus (RSV) is one of the top prospects in its pipeline, but also one with considerable competition, so needs strong data to support the programme.

In a separate development, the European Medicines Agency (EMA) has accepted GSK’s application for a prefilled syringe presentation of recombinant zoster vaccine, Shingrix, for review ...

If she goes, she risks not coming back to her family or her beloved island. Here's where Moana 2 really shows us how far Moana has grown. With age and greater status in Motunui, she's become far ...

Following a two-week interval, a booster vaccination was administered via the subcutaneous route using 2×10 6 PFU of recombinant HSV-vector vaccines. The subsequent assessment of the immune response ...

Authors constructed a novel HSV-based therapeutic vaccine to cure SIV in a primate model ... the authors that no full mechanistic explanation can be given at this moment. (2) No toxicity data are ...

2,3,4 Over 25 million people in Europe have received GSK’s shingles vaccine since 2018 5 GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the ...

In a separate development, the European Medicines Agency (EMA) has accepted GSK’s application for a prefilled syringe presentation of recombinant zoster vaccine, Shingrix, for review, to prevent ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...